These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 2985248)

  • 1. Coordinate inhibition of plasminogen activator and tumor growth by hydrocortisone in mouse mammary carcinoma.
    Mira-y-Lopez R; Reich E; Stolfi RL; Martin DS; Ossowski L
    Cancer Res; 1985 May; 45(5):2270-6. PubMed ID: 2985248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of plasminogen activator in rodent mammary tumors by hormones and other effectors.
    Mira-y-Lopez R; Reich E; Ossowski L
    Cancer Res; 1983 Nov; 43(11):5467-77. PubMed ID: 6684501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model.
    Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP
    J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hormonal modulation of plasminogen activator: an approach to prediction of human breast tumor responsiveness.
    Mira-y-Lopez R; Ossowski L
    Cancer Res; 1987 Jul; 47(13):3558-64. PubMed ID: 3107811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Embryonal mass and hormone-associated effects of pregnancy inducing a differential growth of four murine tumors.
    Bustuoabad OD; di Gianni PD; Franco M; Kordon EC; Vanzulli SI; Meiss RP; Grion LC; Díaz GS; Nosetto SH; Hockl P; Lombardi MG; Pasqualini CD; Ruggiero RA
    Oncol Res; 2002; 13(3):147-60. PubMed ID: 12549624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of endogenous mammary tumor virus expression during hormonal induction of mammary adenoacanthomas and carcinomas of BALB/c female mice.
    McGrath CM; Prass WA; Maloney TM; Jones RF
    J Natl Cancer Inst; 1981 Oct; 67(4):841-52. PubMed ID: 6268884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro and in vivo antisense-mediated growth inhibition of a mammary adenocarcinoma from MMTV-neu transgenic mice.
    Sacco MG; Barbieri O; Piccini D; Noviello E; Zoppé M; Zucchi I; Frattini A; Villa A; Vezzoni P
    Gene Ther; 1998 Mar; 5(3):388-93. PubMed ID: 9614559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Malignant mouse melanoma cells do not form tumors when mixed with cells of a non-malignant subclone: relationships between plasminogen activator expression by the tumor cells and the host's immune response.
    Newcomb EW; Silverstein SC; Silagi S
    J Cell Physiol; 1978 May; 95(2):169-77. PubMed ID: 306389
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced metastasis of Polyoma virus middle T antigen-induced mammary cancer in plasminogen-deficient mice.
    Bugge TH; Lund LR; Kombrinck KK; Nielsen BS; Holmbäck K; Drew AF; Flick MJ; Witte DP; Danø K; Degen JL
    Oncogene; 1998 Jun; 16(24):3097-104. PubMed ID: 9671388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of breast carcinoma tumor growth and lung colonization by overexpression of the soluble urokinase-type plasminogen activator receptor (CD87).
    Krüger A; Soeltl R; Lutz V; Wilhelm OG; Magdolen V; Rojo EE; Hantzopoulos PA; Graeff H; Gänsbacher B; Schmitt M
    Cancer Gene Ther; 2000 Feb; 7(2):292-9. PubMed ID: 10770639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the growth properties in vitro and transplantability of continuous mouse mammary tumor cell lines and clonal derivatives.
    Butel JS; Dudley JP; Medina D
    Cancer Res; 1977 Jun; 37(6):1892-900. PubMed ID: 192465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1.
    Gutierrez LS; Schulman A; Brito-Robinson T; Noria F; Ploplis VA; Castellino FJ
    Cancer Res; 2000 Oct; 60(20):5839-47. PubMed ID: 11059781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NS-398 inhibits tumor growth and liver metastasis of colon cancer through induction of apoptosis and suppression of the plasminogen activation system in a mouse model.
    Nishikawa M; Stapleton PP; Freeman TA; Gaughan JP; Matsuda T; Daly JM
    J Am Coll Surg; 2004 Sep; 199(3):428-35. PubMed ID: 15325613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of vascular endothelial growth factor by tissue inhibitor of metalloproteinase-2: effect on in vivo mammary tumor growth and angiogenesis.
    Hajitou A; Sounni NE; Devy L; Grignet-Debrus C; Lewalle JM; Li H; Deroanne CF; Lu H; Colige A; Nusgens BV; Frankenne F; Maron A; Yeh P; Perricaudet M; Chang Y; Soria C; Calberg-Bacq CM; Foidart JM; Noël A
    Cancer Res; 2001 Apr; 61(8):3450-7. PubMed ID: 11309307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of plasminogen activator activity in human endometrial adenocarcinoma cells by basic fibroblast growth factor and transforming growth factor beta.
    Presta M; Maier JA; Rusnati M; Moscatelli D; Ragnotti G
    Cancer Res; 1988 Nov; 48(22):6384-9. PubMed ID: 3263185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Scatter factor stimulates tumor growth and tumor angiogenesis in human breast cancers in the mammary fat pads of nude mice.
    Lamszus K; Jin L; Fuchs A; Shi E; Chowdhury S; Yao Y; Polverini PJ; Laterra J; Goldberg ID; Rosen EM
    Lab Invest; 1997 Mar; 76(3):339-53. PubMed ID: 9121117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) in the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model.
    Frandsen TL; Holst-Hansen C; Nielsen BS; Christensen IJ; Nyengaard JR; Carmeliet P; Brünner N
    Cancer Res; 2001 Jan; 61(2):532-7. PubMed ID: 11212246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
    Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
    Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone requirements of the pregnancy-dependent mammary tumor of GR/A mice: an in vitro study.
    Harbell JW; Papkoff JS; Daniel CW
    J Natl Cancer Inst; 1982 Dec; 69(6):1391-402. PubMed ID: 6755026
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics of responses to tumor antigens and mouse mammary tumor virus in BALB/cCrgl and BALB/cfC3H mice.
    Lopez DM; Sigel MM; Charyulu VL
    J Natl Cancer Inst; 1981 Jan; 66(1):191-6. PubMed ID: 6256573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.